ReviewClinical kidney journal2026
Myocardial injury in systemic lupus erythematosus and lupus nephritis: a silent threat.
Review in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is associated with significant cardiovascular morbidity, with myocardial involvement representing one of the most clinically significant yet underrecognized cardiac manifestations, largely due to its frequently subclinical presentation and diagnostic complexity. Lupus nephritis (LN), a common and clinically significant manifestation of SLE, is further associated with increased cardiovascular risk, reflecting a dynamic cardiorenal interaction driven by persistent immune activation. Recent advances in cardiovascular imaging techniques have facilitated the early detection of myocardial injury in SLE, improving diagnostic accuracy and enabling timely intervention, but have also uncovered the increased possibility of subclinical, underdiagnosed cases. Herein, this review focuses on myocardial disease in SLE, outlining the diagnostic tools available for early detection of myocardial complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.